Predictions
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€177.98
22.10.20
22.10.20
€170.00
04.11.21
04.11.21
-6.03%
05.11.21
05.11.21
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Rising EBIT margin expected
Leggett & Platt Inc.
Start price
Target price
Perf. (%)
€37.31
22.10.20
22.10.20
-
04.11.21
04.11.21
-6.45%
23.12.20
23.12.20
EBIT growth >5% per year expected
High dividend yield expected
Revenue growth >5% per year expected
Thermo Fisher Scientific Inc.
Start price
Target price
Perf. (%)
€406.60
22.10.20
22.10.20
€580.00
04.11.21
04.11.21
37.09%
05.11.21
05.11.21
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
MGM Resorts International
Start price
Target price
Perf. (%)
€18.70
22.10.20
22.10.20
-
04.11.21
04.11.21
34.77%
30.12.20
30.12.20
Undervalued
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Future proof or reliable business model
Quantafuel ASA
Start price
Target price
Perf. (%)
€4.41
22.10.20
22.10.20
€6.00
04.11.21
04.11.21
7.71%
23.03.21
23.03.21
Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Intuitive Surgical Inc
Start price
Target price
Perf. (%)
€201.33
22.10.20
22.10.20
€216.67
04.11.21
04.11.21
4.35%
07.11.20
07.11.20
Known brand
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Marin Software
Start price
Target price
Perf. (%)
€2.94
21.10.20
21.10.20
€1.00
04.11.21
04.11.21
76.87%
05.11.21
05.11.21
Risky Investment
Astrotech Corp.
Start price
Target price
Perf. (%)
€2.86
21.10.20
21.10.20
-
04.11.21
04.11.21
-69.06%
05.11.21
05.11.21
Risky Investment
Gold Fields Ltd
Start price
Target price
Perf. (%)
€10.40
21.10.20
21.10.20
-
04.11.21
04.11.21
-22.12%
05.11.21
05.11.21
Very high dividend yield expected
Very positive Cash Flow expected
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Gold Fields Ltd. ADR
Start price
Target price
Perf. (%)
€10.70
21.10.20
21.10.20
-
04.11.21
04.11.21
-25.23%
05.11.21
05.11.21
EBIT growth > 30% per year expected
Rising EBIT margin expected
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
DRDGOLD Ltd. ADR
Start price
Target price
Perf. (%)
€10.85
21.10.20
21.10.20
-
04.11.21
04.11.21
-29.94%
05.11.21
05.11.21
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
Harmony Gold Mining ADR
Start price
Target price
Perf. (%)
€4.88
21.10.20
21.10.20
-
04.11.21
04.11.21
-34.22%
12.10.21
12.10.21
Rising EBIT margin expected
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Harmony Gold Mining
Start price
Target price
Perf. (%)
€4.91
21.10.20
21.10.20
-
04.11.21
04.11.21
-36.88%
12.10.21
12.10.21
Undervalued
Very high dividend yield expected
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Intercept Pharmaceuticals
Start price
Target price
Perf. (%)
€25.77
21.10.20
21.10.20
-
04.11.21
04.11.21
-36.63%
05.11.21
05.11.21
Risky Investment
Anavex Life Sciences Corp
Start price
Target price
Perf. (%)
€4.28
21.10.20
21.10.20
€6.00
04.11.21
04.11.21
348.60%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Misonix Inc.
Start price
Target price
Perf. (%)
€10.30
21.10.20
21.10.20
€12.00
02.11.20
02.11.20
-7.28%
02.11.20
02.11.20
Could be worthwhile Investment >10% per year
STS Group AG
Start price
Target price
Perf. (%)
€3.07
21.10.20
21.10.20
€3.00
04.11.21
04.11.21
3.26%
10.11.20
10.11.20
Future proof or reliable business model
Could be very worthwhile Investment >20% year
Leading role in innovation
Revenue growth >5% per year expected
GEA Group AG
Start price
Target price
Perf. (%)
€30.61
20.10.20
20.10.20
€32.00
31.10.20
31.10.20
-6.08%
31.10.20
31.10.20
Capable Management
Good culture
Differentiated customer and product portfolio
Risky Investment